Other
Changes in the fair value of equity securities
Biogen Changes in the fair value of equity securities increased by 3900.0% to $19M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 146.5%, from -$40.9M to $19M.
Analysis
StatementIncome Statement
SectionOther
First reportedQ3 2018
Last reportedQ1 2026Apr 29, 2026
Metric ID:
other_increase_decrease_in_equity_securities_fv_niHistorical Data
11 periods
| Q3 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$426.9M | -$191.1M | -$78.2M | -$79.6M | $106.4M | -$302.5M | -$31.3M | -$30.3M | -$40.9M | -$500K | $19M |
| QoQ Change | — | +55.2% | +59.1% | -1.8% | +233.7% | -384.3% | +89.7% | +3.2% | -35.0% | +98.8% | >999% |
| YoY Change | — | — | — | +58.3% | +236.1% | — | +60.7% | -128.5% | -30.7% | — | +146.5% |
Range-$426.9M – $106.4M
CAGR-71.2%
Avg YoY Growth+57.1%
Median YoY Growth+59.5%
Current Streak2 quarters growth
Frequently Asked Questions
- What is Biogen's changes in the fair value of equity securities?
- Biogen (BIIB) reported changes in the fair value of equity securities of $19M in Q1 2026.
- How has Biogen's changes in the fair value of equity securities changed year-over-year?
- Biogen's changes in the fair value of equity securities increased by 146.5% year-over-year, from -$40.9M to $19M.